MedPath

Prednisolone in Infantile Spasms- High Dose Versus Usual Dose

Phase 3
Completed
Conditions
Infantile Spasms
West Syndrome
Interventions
Registration Number
NCT01575639
Lead Sponsor
Lady Hardinge Medical College
Brief Summary

Infantile spasms comprise a difficult to treat type of epilepsy in young children. Hormonal treatment, i.e. Prednisolone and ACTH are considered the treatment of choice. There is no consensus on the dosage of Prednisolone required for the treatment of infantile spasms. Recent data has shown that a high dose (4 mg/kg/day) may be more efficacious than the usual dose (2 mg/kg/day). However, there are no randomized controlled trials comparing these doses. A higher steroid dose may also be associated with more side effects. Therefore, this study was planned to compare the efficacy and tolerability of the high dose versus the usual dose in children with infantile spasms, in a randomized open-label trial design

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
63
Inclusion Criteria
  • Children aged 3 months to 2 years presenting with epileptic spasms (at least 1 cluster/day) with EEG evidence of hypsarrhythmia or its variants
Read More
Exclusion Criteria
  1. Children with active systemic illness
  2. Children with evidence of active tuberculosis
  3. Severe Acute Malnutrition ad defined by WHO (visible wasting/Mid Upper Arm Circumference < 11 cm/pedal edema/Weight for height < 3 SD)
  4. Children with recurrent illness/chronic systemic illness
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High doseOral prednisoloneOral Prednisolone will be given at dose of 4 mg/kg/day for 14 days
Usual doseOral prednisoloneOral prednisolone will be given at dose of 2 mg/kg/day for 14 days
Primary Outcome Measures
NameTimeMethod
Proportion of children who achieved spasm freedom (for at least 48 hours) as per parental reports on day 14 .14 days
Secondary Outcome Measures
NameTimeMethod
Proportion of children with adverse effects14 days

Trial Locations

Locations (1)

Lady Hardinge Medical College and Associated Kalawati Saran Children's Hospital

🇮🇳

New Delhi, Delhi, India

© Copyright 2025. All Rights Reserved by MedPath